Naloxone for In-Hospital Cardiac Arrest

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 850 participants.

Also called NCT07806565

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 850 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07806565
  • EU CT 2026-525323-24-00
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07806565. Randomized; quadruple masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2030-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Naloxone for In-Hospital Cardiac Arrest
Acronym
naloxone-IHCA
Condition
Heart Arrest
Intervention (Drug)
naloxone
Intervention (Drug)
Placebo
Lead sponsor
Region Skane (class: other)
Collaborator
Lund University (class: other)
Collaborator
Clinical Studies Sweden (class: other)
Collaborator
Copenhagen Trial Unit, Center for Clinical Intervention Research (class: other)

Record details

Record id
cardio:ct-nct07806565
Content hash
3c2d95a3e1dd740430146568522d09da749318e25b8177673cd01a8f6d9b2042